AstraZeneca to apply for Covid-19 vaccine approval in US later in 2021

British-Swedish biopharma giant AstraZeneca on Thursday announced that it would seek approval from the US Food and Drug Administration (FDA) for its vaccines in the second half of this year.

British-Swedish biopharma giant AstraZeneca, which manufactures the Covid-19 vaccine developed by scientists at the University of Oxford, on Thursday indicated that they would seek approval from the US medicines regulator for its jabs in the second half of this year. The AZD1222 vaccine, also being produced under licence by the Serum Institute of India (SII) as Covishield and approved for human use by the UK and European medicines regulators, is pending a US Food and Drug Administration (USFDA) application.